A
Aladdin J Mohammad
Researcher at University of Cambridge
Publications - 90
Citations - 2657
Aladdin J Mohammad is an academic researcher from University of Cambridge. The author has contributed to research in topics: Population & Vasculitis. The author has an hindex of 22, co-authored 71 publications receiving 1769 citations. Previous affiliations of Aladdin J Mohammad include University of Pennsylvania & University of Iceland.
Papers
More filters
Journal ArticleDOI
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa
TL;DR: The incidence of WG and MPA was equal in the authors' district, but there was a difference in survival rates related to age and renal function, which was not significant in the multivariate analysis.
Journal ArticleDOI
Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg–Strauss syndrome within a defined population in southern Sweden
TL;DR: The prevalence of Wegener's granulomatosis, microscopic polyangiitis, MPA, PAN and CSS in southern Sweden is the highest figure reported so far and may include high incidence, extensive ANCA-testing, good survival as well as sensitive search methods for case identification.
Journal ArticleDOI
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
Aladdin J Mohammad,Arnaud Hot,F Arndt,Frank Moosig,M-J Guerry,N. Amudala,Rona M Smith,Pasupathy Sivasothy,Loïc Guillevin,Peter A. Merkel,David Jayne +10 more
TL;DR: The treatment of EGPA with rituximab resulted in high rates of improvement and reduced requirement of prednisolone, and may be considered for the treatment ofEGPA.
Journal ArticleDOI
Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Richard A. Watts,Alfred Mahr,Aladdin J Mohammad,Paul A. Gatenby,Neil Basu,Luis Felipe Flores-Suárez +5 more
TL;DR: The vasculitides are rare, and therefore, a large population is required to determine the incidence and prevalence, and this poses questions of feasibility, whereas a smaller population requires a much longer time frame to collect the necessary cases, which may not be feasible.
Journal ArticleDOI
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.
Gunnar Tomasson,Christine Peloquin,Aladdin J Mohammad,Thorvardur Jon Love,Yuqing Zhang,Hyon K. Choi,Peter A. Merkel +6 more
TL;DR: This population-based cohort study found increased risks for myocardial infarction, cerebrovascular accident, and peripheral vascular disease among patients with giant-cell arteritis, particularly in the first month after the diagnosis of GCA.